TY - JOUR
T1 - Disseminated Mycobacterium avium complex infection mimicking malignancy in a patient with anti-IFN-γautoantibodies
T2 - A case report
AU - Yeh, Yun Kai
AU - Ding, Jing Ya
AU - Ku, Cheng Lung
AU - Chen, Wei Chih
N1 - Publisher Copyright:
© 2019 The Author(s).
PY - 2019/10/29
Y1 - 2019/10/29
N2 - Background: Disseminated nontuberculous mycobacteria (NTM) infections occur mostly in immunocompromised patients. Therefore, it is difficult to diagnose disseminated NTM infections in patients without history of immunocompromised diseases or using immunosuppressant. Patients with anti-interferon-γ(IFN-γ) autoantibodies are vulnerable to intracellular infections, such as disseminated NTM. Currently, there is no widely used and efficient technique for the detection of anti-IFN-γautoantibodies. Herein, we report a case of an apparently healthy patient with disseminated Mycobacterium avium complex (MAC) infection who tested positive for anti-IFN-γautoantibodies. Case presentation: A 64-year-old non-immunocompromised and apparently healthy Asian male presented to the emergency department with complaints of progressive chest pain for about 6 months and weight loss. A bulging tumour was found in the anterior chest wall. Chest computed tomography showed a lung mass over the right lower lobe and an osteolytic lesion with a soft tissue component at the sternum. Sonography-guided biopsies for the osteolytic lesion and sputum culture confirmed the presence of disseminated MAC infection. In addition, positive test result of anti-IFN-γautoantibodies was noted. The patient was prescribed antibiotics. The lesions over the right lower lobe and sternum attenuated following the antibiotic treatment. Conclusion: Detection of anti-IFN-γautoantibodies is important among previously healthy people with disseminated NTM infection. Presence of anti-IFN-γautoantibodies may suggest a high risk of severe intracellular infection, such as disseminated NTM infection.
AB - Background: Disseminated nontuberculous mycobacteria (NTM) infections occur mostly in immunocompromised patients. Therefore, it is difficult to diagnose disseminated NTM infections in patients without history of immunocompromised diseases or using immunosuppressant. Patients with anti-interferon-γ(IFN-γ) autoantibodies are vulnerable to intracellular infections, such as disseminated NTM. Currently, there is no widely used and efficient technique for the detection of anti-IFN-γautoantibodies. Herein, we report a case of an apparently healthy patient with disseminated Mycobacterium avium complex (MAC) infection who tested positive for anti-IFN-γautoantibodies. Case presentation: A 64-year-old non-immunocompromised and apparently healthy Asian male presented to the emergency department with complaints of progressive chest pain for about 6 months and weight loss. A bulging tumour was found in the anterior chest wall. Chest computed tomography showed a lung mass over the right lower lobe and an osteolytic lesion with a soft tissue component at the sternum. Sonography-guided biopsies for the osteolytic lesion and sputum culture confirmed the presence of disseminated MAC infection. In addition, positive test result of anti-IFN-γautoantibodies was noted. The patient was prescribed antibiotics. The lesions over the right lower lobe and sternum attenuated following the antibiotic treatment. Conclusion: Detection of anti-IFN-γautoantibodies is important among previously healthy people with disseminated NTM infection. Presence of anti-IFN-γautoantibodies may suggest a high risk of severe intracellular infection, such as disseminated NTM infection.
KW - Anti-interferon-γautoantibodies
KW - Mycobacterium avium complex
KW - Nontuberculous mycobacteria
KW - Sonography-guided biopsy
UR - http://www.scopus.com/inward/record.url?scp=85074373505&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85074373505&partnerID=8YFLogxK
U2 - 10.1186/s12879-019-4564-4
DO - 10.1186/s12879-019-4564-4
M3 - Article
C2 - 31664931
AN - SCOPUS:85074373505
SN - 1471-2334
VL - 19
JO - BMC Infectious Diseases
JF - BMC Infectious Diseases
IS - 1
M1 - 909
ER -